IMS Health is prepping for an initial public offering, which could value the health-tech company at up to $6.97 billion.

IMS said it expects to price its initial public offering at $18 to $21 per share. The Danbury, Conn.-based company said the sale of 65 million shares was expected to raise about $1.36 billion, based on the top end of the price range.